about
Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In Vivo.The mechanism of monomer transfer between two structurally distinct PrP oligomersForce spectroscopy reveals the presence of structurally modified dimers in transthyretin amyloid annular oligomers.Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation.Establishing and validating the fluorescent amyloid ligand h-FTAA (heptamer formyl thiophene acetic acid) to identify transthyretin amyloid deposits in carpal tunnel syndrome.Influence of C-terminal truncation of murine Serum amyloid A on fibril structure.MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.Molecular Origins of the Compatibility between Glycosaminoglycans and Aβ40 Amyloid FibrilsRole of the N-terminus for the stability of an amyloid-β fibril with three-fold symmetry.C-Terminal Truncated α-Synuclein Fibrils Contain Strongly Twisted β-Sheets.Amyloid fibril polymorphism - a challenge for molecular imaging and therapy.Covalent Tethering and Residues with Bulky Hydrophobic Side Chains Enable Self-Assembly of Distinct Amyloid Structures.Physical basis of amyloid fibril polymorphism.Single-molecule probing of amyloid nano-ensembles using the polymer nanoarray approach.No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.Mass and charge distributions of amyloid fibers involved in neurodegenerative diseases: mapping heterogeneity and polymorphism.
P2860
Q30313147-1C00F292-C112-4B45-8689-D31C0D580E16Q38660200-B913B52E-7BDA-4A44-98E3-C4F96B04F0BEQ39221178-62A1D2C5-8E8A-4582-B356-6A6B12688682Q39385143-12DEDB31-B731-463A-8F42-311527BC8444Q40463135-A3F79C27-ED79-4571-A1F0-B5CB22AC2E14Q41094376-A91F540C-F7FD-4A58-A2C5-7C2CF571D530Q41136625-506205E0-2D21-4F75-A68B-BD71E213586CQ41301732-DA88499E-3FEB-4A73-886D-3C9732E355CAQ42375852-6A4F2B8E-3B2C-4D9E-98E0-4E2E57DA784AQ44470865-C643AC1C-AA26-4E91-8806-3B67B52C1E10Q47717455-E4FBD047-1E6C-4507-ACF7-0F1A22DA9351Q48314753-20989C5E-2A97-4870-9302-CB024F6F7BA3Q49913157-C7E460A1-988E-4791-A839-112ED324ED22Q50941257-A2520226-465E-4D68-BFFD-18C16E6A03C7Q53698735-6162B199-3C2B-4C11-8CFD-AB198C7C978BQ55078380-07C73221-F5DF-4F45-9B97-BB8DC454C45B
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Polymorphism of Amyloid Fibrils In Vivo.
@en
Polymorphism of Amyloid Fibrils In Vivo.
@nl
type
label
Polymorphism of Amyloid Fibrils In Vivo.
@en
Polymorphism of Amyloid Fibrils In Vivo.
@nl
prefLabel
Polymorphism of Amyloid Fibrils In Vivo.
@en
Polymorphism of Amyloid Fibrils In Vivo.
@nl
P2093
P2860
P356
P1476
Polymorphism of Amyloid Fibrils In Vivo
@en
P2093
Christina J Sigurdson
Cornelia Loos
Henri Michel
Karl-Heinz Gührs
Karthikeyan Annamalai
Marcus Fändrich
Matthias Schmidt
Patricia M Gaffney
Rolf Koehler
Ute Hegenbart
P2860
P304
P356
10.1002/ANIE.201511524
P407
P577
2016-03-08T00:00:00Z